Sixty-seven cases of chronic hepatitis were treated with Radix Astragali. After treatment(2-month course) . the clinical improvement rate in 38 cases ot the Stagnation of the Liver-Qi and Defi-ciency of the Spleen typ...Sixty-seven cases of chronic hepatitis were treated with Radix Astragali. After treatment(2-month course) . the clinical improvement rate in 38 cases ot the Stagnation of the Liver-Qi and Defi-ciency of the Spleen type was 92. 1%. and in 26 cases of the Deficiency of Liver Yin and Kidney Yin typewas 88. 5% , more effective than in the control group (P<O. 05) . The regulative effect to the levels ofserum hormone was observed in the patients of the Stagnation of the Liver-Qi and Deficiency of the Spleentype treated with this medicine. The results showed that the levels of serum triiodothyronine, estradiol(female) and testosterone (male) were increased after treatment (1. 40 1. 38 ng/dl, 129. 30 1. 23 pg/ml and 496. 24 1. 47 ng/dl) . Pretreatment levels were 1. 22 1. 49 ng/dl, 104. 60 1. 45 pg/ml and 398.17 1. 55 ng/dl respectively (P<O. 05) . however, the level ot serum prolactin (2. 75 4. 46 ng/ml) waslower after treatment than before treatment (3. 20 3. 82 ng/ml, P<O. 05) . No obvious changes were ob-served in the levels of serum follicle stimulating hormone. luteinizing hormone, thyroid stimulating hor-mone, thyroxine, triiodothyronine uptake ratio and cortisol after treatment.展开更多
文摘Sixty-seven cases of chronic hepatitis were treated with Radix Astragali. After treatment(2-month course) . the clinical improvement rate in 38 cases ot the Stagnation of the Liver-Qi and Defi-ciency of the Spleen type was 92. 1%. and in 26 cases of the Deficiency of Liver Yin and Kidney Yin typewas 88. 5% , more effective than in the control group (P<O. 05) . The regulative effect to the levels ofserum hormone was observed in the patients of the Stagnation of the Liver-Qi and Deficiency of the Spleentype treated with this medicine. The results showed that the levels of serum triiodothyronine, estradiol(female) and testosterone (male) were increased after treatment (1. 40 1. 38 ng/dl, 129. 30 1. 23 pg/ml and 496. 24 1. 47 ng/dl) . Pretreatment levels were 1. 22 1. 49 ng/dl, 104. 60 1. 45 pg/ml and 398.17 1. 55 ng/dl respectively (P<O. 05) . however, the level ot serum prolactin (2. 75 4. 46 ng/ml) waslower after treatment than before treatment (3. 20 3. 82 ng/ml, P<O. 05) . No obvious changes were ob-served in the levels of serum follicle stimulating hormone. luteinizing hormone, thyroid stimulating hor-mone, thyroxine, triiodothyronine uptake ratio and cortisol after treatment.
